Table. Demographics, Disease Severity, and Vaccine Reactogenicity.
| Demographics | Participants, No. (%) (N = 63) | |
|---|---|---|
| Vaccinated (n = 15) | Not vaccinated (n = 48) | |
| Age, mean (range), y | 14.4 (12-18) | 15.3 (12-21) |
| Male | 10 (67) | 27 (56) |
| Female | 5 (33) | 21 (44) |
| BMI, mean (range) | 25.1 (18.9-44.8) | 26.5 (16.7-48.8) |
| Racial or ethnic minority groupa | 10 (67) | 39 (81) |
| Disease severity | ||
| Intensive care | 10 (73) | 33 (69) |
| Hypotension | 11 (73) | 33 (69) |
| Ionotropic support | 5 (33) | 27 (56) |
| Intubation | 2 (13) | 11 (23) |
| Received corticosteroids | 15 (100) | 48 (100) |
| Received high dose immunoglobulin | 11 (73) | 34 (71) |
| Received anakinra | 10 (67) | 37 (77) |
| Length of stay, mean (range), d | 10.9 (2-33) | 11.4 (3-55) |
| Vaccine reactogenicity (n = 12)b | ||
| Local site | ||
| Pain | 7 (58) | NA |
| Redness | 0 | NA |
| Swelling | 0 | NA |
| Systemic | NA | |
| Fatigue | 4 (33) | NA |
| Headache | 4 (33) | NA |
| Myalgia | 0 | NA |
| Fever | 1 (8) | NA |
| Nausea | 1 (8) | NA |
Abbreviations: BMI indicates body mass index, which is calculated as weight in kilograms divided by height in meters squared; NA, not applicable.
a
For this study, racial and ethnic minority groups include Asian patients, Black patients, and Hispanic patients.
b
Three Patients did not directly report.